Literature DB >> 16303287

Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis.

A K Cross1, G Haddock, J Surr, J Plumb, R A D Bunning, D J Buttle, M N Woodroofe.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an animal model of inflammatory demyelination, a pathological event common to multiple sclerosis (MS). During CNS inflammation there are alterations in the extracellular matrix (ECM). A Disintegrin and Metalloproteinase with Thrombospondin motifs (ADAMTS)-1, -4 and -5 are proteases present in the CNS, which are able to cleave the aggregating chondroitin sulphate proteoglycans, aggrecan, phosphacan, neurocan and brevican. It is therefore important to investigate changes in their expression in different stages of EAE induction. We have investigated expression of ADAMTS-1, -4, -5 and tissue inhibitor of metalloproteinase (TIMP)-3, by real-time RT-PCR. We have also examined protein expression of ADAMTS-1, -4 and -5 by western blotting and immunocytochemistry in spinal cord from animals at different stages of disease progression. Our study demonstrated a decrease in ADAMTS-4 mRNA and protein expression. TIMP-3 was decreased at the mRNA level although protein levels were increased in diseased animals compared to controls. Our study identifies changes in ADAMTS expression during the course of CNS inflammation which may contribute to ECM degradation and disease progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303287     DOI: 10.1016/j.jaut.2005.09.026

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

2.  Increased metalloproteinase activity in the hippocampus following status epilepticus.

Authors:  Deepti Dubey; Paulette A McRae; Elyse K Rankin-Gee; Esther Baranov; Luke Wandrey; Stephanie Rogers; Brenda E Porter
Journal:  Epilepsy Res       Date:  2017-03-01       Impact factor: 3.045

Review 3.  Pathophysiological Function of ADAMTS Enzymes on Molecular Mechanism of Alzheimer's Disease.

Authors:  Murat Serdar Gurses; Mustafa Numan Ural; Mehmet Akif Gulec; Omer Akyol; Sumeyya Akyol
Journal:  Aging Dis       Date:  2016-01-11       Impact factor: 6.745

4.  Whither autoimmunity: the lessons of anti-CCP and B cell depletion.

Authors:  Yehuda Shoenfeld; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

5.  Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension.

Authors:  Michelle G Hamel; Joanne M Ajmo; Christopher C Leonardo; Fengrong Zuo; John D Sandy; Paul E Gottschall
Journal:  Exp Neurol       Date:  2007-12-03       Impact factor: 5.330

Review 6.  Cell damage and autoimmunity: a critical appraisal.

Authors:  Ian R Mackay; Natasha V Leskovsek; Noel R Rose
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

7.  Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes.

Authors:  Regina Coeli Dos Santos Goldenberg; Dumitru A Iacobas; Sanda Iacobas; Leonardo Lima Rocha; Fabio da Silva de Azevedo Fortes; Leandro Vairo; Fnu Nagajyothi; Antonio Carlos Campos de Carvalho; Herbert B Tanowitz; David C Spray
Journal:  Microbes Infect       Date:  2009-09-01       Impact factor: 2.700

8.  The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.

Authors:  Ryoji Tauchi; Shiro Imagama; Takamitsu Natori; Tomohiro Ohgomori; Akio Muramoto; Ryuichi Shinjo; Yukihiro Matsuyama; Naoki Ishiguro; Kenji Kadomatsu
Journal:  J Neuroinflammation       Date:  2012-03-15       Impact factor: 8.322

Review 9.  ADAMTS proteoglycanases in the physiological and pathological central nervous system.

Authors:  Sighild Lemarchant; Mathilde Pruvost; Joan Montaner; Evelyne Emery; Denis Vivien; Katja Kanninen; Jari Koistinaho
Journal:  J Neuroinflammation       Date:  2013-10-31       Impact factor: 8.322

10.  Discordant localization of WFA reactivity and brevican/ADAMTS-derived fragment in rodent brain.

Authors:  Joanne M Ajmo; Autumn K Eakin; Michelle G Hamel; Paul E Gottschall
Journal:  BMC Neurosci       Date:  2008-01-25       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.